Study Summary
This is a multicentre observational study with the aim of evaluating the antibody and cellular response after vaccination for SARS-CoV-2 with Pfizer-BioNTech or Moderna vaccines in frail subjects with impaired immuno-competence, due to their underlying diseases or ongoing therapies.
Want to learn more about this trial?
Request More InfoInterventions
COVID-19 vaccinesBIOLOGICAL
This is an observational prospective study whose general objective is to assess the impact of COVID-19 vaccination in terms of induction of humoral and cell-mediated immune responses in selected fragile (altered immunocompetence) populations.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| IRCCS Istituto Tumori Giovanni Paolo II | Bari | Bari | Italy |
| IRCCS Azienda Ospedaliera Universitaria | Bologna | Bologhna | Italy |
| Ospedale Policlinico San Martino IRCCS | Genova | Genova | Italy |
| Foindazione IRCCS Istituto Neurologico Carlo Besta | Milan | Milano | Italy |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan | Milano | Italy |
| IRCCS Istituto Clinico Humanitas | Milan | Milano | Italy |
| IRCCS Ospedale San Raffaele | Milan | Milano | Italy |
| Fondazione IRCCS Policlinico San Matteo | Pavia | Pavia | Italy |
| Azienda USL IRCCS di Reggio Emilia | Reggio Emilia | Reggio Emilia | Italy |
| IRCCS Istituto Nazionale Tumori Regina Elena | Roma | Roma | Italy |
| IRCCS Istituto per le Malattie Infettive Lazzaro Spallanzani | Roma | Roma | Italy |
| Istituto Dermatologico San Gallicano | Roma | Roma | Italy |